Related references
Note: Only part of the references are listed.Toll-like receptor 7 (TLR7)-driven accumulation of a novel CD11c+ B-cell population is important for the development of autoimmunity
Anatoly V. Rubtsov et al.
BLOOD (2011)
Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial
Sandra V. Navarra et al.
LANCET (2011)
Dissecting the Immune Cell Mayhem That Drives Lupus Pathogenesis
Joseph E. Craft
SCIENCE TRANSLATIONAL MEDICINE (2011)
Neutrophils Activate Plasmacytoid Dendritic Cells by Releasing Self-DNA-Peptide Complexes in Systemic Lupus Erythematosus
Roberto Lande et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Mechanisms of B cell autoimmunity in SLE
Thomas Doerner et al.
ARTHRITIS RESEARCH & THERAPY (2011)
Risk Alleles for Systemic Lupus Erythematosus in a Large Case-Control Collection and Associations with Clinical Subphenotypes
Kimberly E. Taylor et al.
PLOS GENETICS (2011)
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of Belimumab in Patients With Active Systemic Lupus Erythematosus
Daniel J. Wallace et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2009)
AIRE regulates T-cell-independent B-cell responses through BAFF
Emma Lindh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Neutrophil extracellular traps kill bacteria
V Brinkmann et al.
SCIENCE (2004)
Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors
EA Leadbetter et al.
NATURE (2002)
Share Paper
